Dyslipidemia across the menopause transition: Mechanisms, trajectories, and opportunities for cardiovascular prevention.

Authors

Regina Castaneda, Caroline P Tatit, Maria D Hurtado Andrade, Stephanie S Faubion, Chrisandra L Shufelt

Published in

Maturitas. Volume 212. Pages 109058. Jul 17, 2026. Epub Jul 17, 2026.

Abstract

The menopause transition is associated with a notable increase in the risk of cardiovascular disease (CVD), making this period a critical window for early prevention and intervention. This heightened CVD risk is driven in part by adverse changes in lipid metabolism. As estrogen levels decline, women experience significant increases in low-density lipoprotein cholesterol (LDL-C) and triglycerides, along with alterations in high-density lipoprotein cholesterol (HDL-C) composition and function that reduce its cardioprotective properties. These lipid changes occur independent of chronological aging, with the most pronounced increases occurring within one year of the final menstrual period. Dyslipidemia is an important modifiable risk factor for CVD during this life stage. Evidence-based lifestyle interventions, such as Mediterranean and Dietary Approaches to Stop Hypertension (DASH) dietary patterns along with regular aerobic or resistance training, can help mitigate these adverse lipid changes. Additional behavioral modifications, including smoking cessation and limiting alcohol intake, further reduce cardiovascular risk. When lifestyle interventions are insufficient, statins remain first-line therapy for dyslipidemia management. While menopausal hormone therapy favorably affects lipid profiles, current guidelines do not recommend its use for dyslipidemia management or CVD prevention due to inconsistent benefits and potential risks. This review evaluates current evidence on dyslipidemia across the menopause transition, distinguishing menopause-related lipid changes from those of chronological aging, and examines the impact of modifiable lifestyle factors and therapeutic interventions on lipid trajectories during this reproductive stage.

PMID:
42468089
Bibliographic data and abstract were imported from PubMed on 18 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.